Loading
Sentiment · FY2026 Q2
As of FY2026 Q1, the Tellvest earnings-call sentiment score for Intuitive Surgical (ISRG) is 9/10.
Intuitive Surgical delivered robust Q1 2026 results with revenue up 23% to $2.77 billion and GAAP EPS of $2.28, up from $1.92 in the prior year, as total procedures grew 17% across all platforms. Management raised FY2026 da Vinci procedure growth guidance to 13.5-15.5% and non-GAAP gross margin to 67.5-68.5%, reflecting innovation-led revenue premiums above procedure growth. Force Feedback instrumentation broadened availability, and SP platform expansion continued with stapler and new procedure additions. China market headwinds persisted but strong operating margin leverage and cost execution supported earnings growth.
Scored from Intuitive Surgical’s FY2026 Q1 earnings call. The newest quarter is available with Tellvest Pro.
Full Pro access for 30 days when you create a free account. No credit card required.
All prior quarters are free.
| Quarter | Revenue | Rev YoY | EPS | EPS YoY | Gross margin | Op margin | Net margin | FCF |
|---|---|---|---|---|---|---|---|---|
| FY2024 Q4 | $2.41B | +25.2% | $1.88 | +11.2% | 68.0% | 30.4% | 28.4% | $511M |
| FY2025 Q1 | $2.25B | +19.2% | $1.92 | +27.2% | 64.7% | 25.7% | 31.0% | $465M |
| FY2025 Q2 | $2.44B | +21.4% | $1.81 |
| +24.0% |
| 66.3% |
| 30.5% |
| 27.0% |
| $560M |
| FY2025 Q3 | $2.51B | +22.9% | $1.95 | +25.0% | 66.4% | 30.3% | 28.1% | $736M |
| FY2025 Q4 | $2.87B | +18.8% | $2.21 | +17.6% | 66.4% | 30.2% | 27.7% | $730M |
| FY2026 Q1 | $2.77B | +23.0% | $2.28 | +18.8% | 66.1% | 30.9% | 29.6% | $809M |
| FY2026 Q2 | $2.89B | +18.5% | $2.35 | +29.8% | 67.8% | 33.6% | 28.3% | $948M |